Large-scale testing (Phase 3)Study completedNCT01032408
What this trial is testing
Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection
Who this might be right for
H1N1 Influenza VirusHuman Immunodeficiency Virus Type 1 (HIV-1) Infection
Chiltern Pesquisa Clinica Ltda 154